![Apostle MiniEnrich EMS Panel v1.0, 96 rxn Apostle MiniEnrich EMS Panel v1.0, 96 rxn](https://apostlebio.com/image/cache/catalog/NGS/DNA_ps_formatted/MiniEnrich%20EMS%20Panel%20v1.0_96.jpg-out-550x688h.jpg)
Introduction
Apostle MiniEnrich EMS Panel v1.0 (Early Methylation for Screening) covers methylation gene sites related to nine major high-incidence cancers, including selected sites approved by the NMPA and FDA, as well as those reported in literature and patents. It encompasses nine types of cancers, including lung cancer, colorectal cancer, gastric cancer, liver cancer, breast cancer, carcinoma cancer, prostate cancer, cervical cancer, and ovarian cancer, involving 76 methylated candidate genes associated with carcinogenesis and tumor suppression, with over 2,000 CpG sites. The probe design covers approximately 20 Kb of the human genome, providing comprehensive and accurate support for methylation early screening.
Species of Cancer | Biomarker |
Lung Cancer | SCT, HOXA7, RASSF1, SHOX2, PTGER4 |
Colorectal Carcinoma | NDRG4, BCAT1, SEPTIN9, BMP3, TFPI2, SDC2, SFRP2 |
Gastric Cancer | SEPTIN9, RNF180, TCF4, RPRM, SDC2, TERT |
Liver Cancer | SCN48, BDH1, HOXA10, PLAC8, BMPR1A, TEPP, SPACA6, MIXL1, TSC22D1 |
Breast Cancer | CDO1, PITX2, GSTP1, GP5, APC |
Carcinoma Cancer | SOX1, GALR1, DMRTA2, EVX2, SOX17, DCHS2, TWIST1, TBX5, HOXA11, SIM2, LHX2 |
Prostatic Cancer | CCND2, CDH1, MCAM, PENK, PITX2, PTGS2, RARB, LINC02028, SLCO3A1, HES5, TPM4, FHAD1, SOX1-OT, IGFBP3, ZNF154, FEZF2, APC |
Cervical Cancer | SOX1, PAX1, JAM3, TAFA4, ASTN1, DLX1, ITGA4, RXFP3, SOX17 |
Ovarian Cancer | PCDHB18P, CDO1, HOXA9, LYPD5, CDH13, FOXD3, ZNF671, HOXA11, FBXO32, OPCML, BLACAT1, LRRC41, GNE, FAIM2, CAPN2, SIM2 |
Information
Cat # | NA003212 |
Capacity | 96 rxn |
Performance | Check information page |
Protocol |